G1 THERAPEUTICS INC (GTHX)
US3621LQ1099 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 32.22M | 94.60M | 221.20M | 207.30M | 269.20M | |||
| Marketable Securities | 49.94M | 50.50M | N/A | N/A | N/A | |||
| Receivables | 12.69M | 11.10M | 5.70M | 200.00K | N/A | |||
| Inventories | 12.44M | 16.20M | 3.50M | N/A | N/A | |||
| Other Current Assets | 7.66M | 7.20M | 13.30M | 8.90M | 1.80M | |||
| Total Current Assets | 114.95M | 179.50M | 243.60M | 216.40M | 271.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.38M | 8.00M | 9.00M | 10.50M | 13.40M | |||
| Other Non-Current Assets | 208.00K | 500.00K | 1.50M | 1.70M | 400.00K | |||
| Total Non-Current Assets | 6.59M | 8.50M | 10.50M | 12.20M | 13.80M | |||
| TOTAL ASSETS | 121.54M | 188.00M | 254.10M | 228.60M | 284.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 23.17M | 26.70M | 24.30M | 17.50M | 16.10M | |||
| Accounts Payable | 3.99M | 7.40M | 2.90M | 3.60M | 3.70M | |||
| Other Current Liabilities | 2.56M | 1.50M | 400.00K | 2.40M | N/A | |||
| Total Current Liabilities | 29.72M | 35.60M | 27.60M | 23.40M | 19.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 51.56M | 77.00M | 75.20M | 19.90M | 0.00 | |||
| Other Non-Current Liabilities | 4.88M | 6.60M | 7.80M | 7.90M | 9.50M | |||
| Total Non-Current Liabilities | 56.44M | 83.60M | 83.00M | 27.80M | 9.50M | |||
| TOTAL LIABILITIES | 86.15M | 119.20M | 110.60M | 51.20M | 29.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -779.99M | -732.00M | -584.50M | -436.10M | -336.90M | |||
| Additional Paid In Capital | 815.37M | 800.80M | 728.00M | 613.50M | 592.40M | |||
| Common Shares | 5.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -8.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 51.93M | 51.50M | 42.60M | 38.10M | 37.60M | |||
| Tangible Book Value per Share | 0.68 | 1.33 | 3.37 | 4.66 | 6.80 | |||
| Total Shareholders' Equity | 35.39M | 68.70M | 143.50M | 177.40M | 255.50M | |||
| TOTAL LIABILITIES AND EQUITY | 121.54M | 188.00M | 254.10M | 228.60M | 284.80M | |||
| Statistics | ||||||||
| Debt/Equity | 1.46 | 1.12 | 0.52 | 0.11 | N/A | |||
| Current Ratio | 3.87 | 5.04 | 8.83 | 9.25 | 13.69 | |||
| Return On Assets (ROA) | -39.47% | -78.49% | -58.38% | -43.42% | -43.00% | |||
| Return On Equity (ROE) | -135.55% | -214.79% | -103.38% | -55.95% | -47.93% | |||
All data in USD